malaria
Breathalyser for malaria shows promise in trials
November 7, 2017Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical
Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …
‘Super malaria’ sweeps South East Asia
September 25, 2017Medical Communications, Sales and Marketing biotech, drug resistance, drug-resistance, drugs, malaria, pharma, pharmaceutical
There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …
Novartis begins ‘next-generation’ malaria treatment trial
August 21, 2017Research and Development, Sales and Marketing MMV, Novartis, biotech, drugs, malaria, pharma, pharmaceutical
Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …
Pulses of light may offer ward against mosquitos
June 19, 2017Research and Development, Sales and Marketing malaria, mosquito
Research emerging from scientists at the University of Notre Dame has found that exposing mosquitos to light during the night …
Weakness discovered in malaria parasite could lead to new treatment
June 15, 2017Protein, anti-malarial drug resistance, malaria, mosquito
A protein has been newly discovered that could lead to an alternative form of vaccination against the spread of malaria …
Malaria expected to be eradicated from 15 Indian states by 2020
May 15, 2017Research and Development, Sales and Marketing India, antimalarial drug resistance, malaria
In good news in the fight against antimalarial drug resistance, the Director of the National Vector Borne Disease Control Programme …
Insider Interview: The battle to defeat antimalarial drug resistance
May 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medicines for Malaria Venture, antimalarial drug resistance, malaria
Pharmafocus spoke to Dr Harald Nusser, Head of Novartis Social Business, and David Reddy, CEO of Medicines for Malaria Venture …
Malaria vaccine displays 100% success rate in clinical trial
February 16, 2017Research and Development Vaccine, malaria
A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …
First-line malaria treatment fails for the first time in UK
January 31, 2017Manufacturing and Production, Research and Development UK, malaria
The key combination malaria therapy artemether-lumefantrine has failed to treat UK patients for the first time, suggesting that the parasite …
UK Government commits £1 billion to malaria fight
January 26, 2016Manufacturing and Production Bill Gates, Chancellor, George Osborne, Ross Fund, infectious diseases, malaria
Chancellor George Osborne has set out details of a billion pound fund to develop, test and produce new products to …
GSK in malaria collaboration with Comic Relief
December 15, 2015Manufacturing and Production Comic Relief, GSK, corporate social responsibility, csr, malaria
GSK and UK-based charity Comic Relief have launched a five-year partnership to fight malaria and improve health in five countries …
Novartis reaches 300 million free antimalarial treatments
December 9, 2015Manufacturing and Production, Research and Development Coartem, Novartis, antimalarial treatment, malaria, non-profit
Novartis has reached a delivery milestone of 300 million paediatric antimalarial treatments, having supplied its Coartem dispersible without profit to …
Infectious diseases dominate Nobel Prize awards for medicine
October 8, 2015Manufacturing and Production, Research and Development Nobel Prize, artemisinin, ivermectin, malaria, mectizan, river blindness
Pharma researchers have been awarded the 2015 Nobel Prize for their work on a river blindness treatment, along with work …
EMA backs GSK’s malaria vaccine for use in Africa
July 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Committee for Medicinal Products for Human USE, EMA, European Medicines Agency, GSK, WHO, malaria, world health organization
GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …
Novartis receives WHO nod for malaria drug Coartem
July 17, 2015Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization
The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …
Latest content
FibroFind appoints Lee Borthwick as CEO
